SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-011320
Filing Date
2020-06-17
Accepted
2020-06-17 09:00:30
Documents
25
Period of Report
2020-06-17
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 29881
2 ex99-1.htm EX-99.1 24080
3 ex99-1_01.jpg GRAPHIC 66393
4 ex99-1_02.jpg GRAPHIC 185941
5 ex99-1_03.jpg GRAPHIC 77002
6 ex99-1_04.jpg GRAPHIC 111958
7 ex99-1_05.jpg GRAPHIC 86133
8 ex99-1_06.jpg GRAPHIC 56198
9 ex99-1_07.jpg GRAPHIC 62933
10 ex99-1_08.jpg GRAPHIC 75660
11 ex99-1_09.jpg GRAPHIC 108555
12 ex99-1_10.jpg GRAPHIC 88052
13 ex99-1_11.jpg GRAPHIC 51403
14 ex99-1_12.jpg GRAPHIC 89991
15 ex99-1_13.jpg GRAPHIC 84707
16 ex99-1_14.jpg GRAPHIC 71501
17 ex99-1_15.jpg GRAPHIC 46948
18 ex99-1_16.jpg GRAPHIC 77835
19 ex99-1_17.jpg GRAPHIC 86841
20 ex99-1_18.jpg GRAPHIC 66192
21 ex99-1_19.jpg GRAPHIC 45432
22 ex99-1_20.jpg GRAPHIC 98745
23 ex99-1_21.jpg GRAPHIC 112583
24 ex99-1_22.jpg GRAPHIC 112002
25 ex99-1_23.jpg GRAPHIC 29836
  Complete submission text file 0001493152-20-011320.txt   2664493
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Filer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37648 | Film No.: 20968142
SIC: 2835 In Vitro & In Vivo Diagnostic Substances